Repeatability of inflammatory parameters in induced sputum of COPD patients

COPD: Journal of Chronic Obstructive Pulmonary Disease

Volumn 4, Issue 4, 2007, Pages 321-329

  Boorsma, Martin ^a   Lutter, René ^a   Van De Pol, Marianne A ^a   Out, Theo A ^a   Jansen, Henk M ^a   Jonkers, René E ^a,b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Chronic obstructive pulmonary disease; Induced sputum; Inflammation; Repeatability

Indexed keywords

ADULT; AGED; ARTICLE; CELL ACTIVATION; CELL COUNT; CELL DIFFERENTIATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; EOSINOPHIL; FEMALE; HUMAN; MACROPHAGE; MALE; MEMBRANE PERMEABILITY; NEUTROPHIL; PRIORITY JOURNAL; SPUTUM ANALYSIS;

ADULT; AGED; BIOLOGICAL MARKERS; CELL COUNT; CELL MEMBRANE PERMEABILITY; ENZYME-LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL CATIONIC PROTEIN; EOSINOPHILS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFLAMMATION; INTERLEUKIN-8; MALE; MIDDLE AGED; NEUTROPHILS; PEROXIDASE; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY MUCOSA; SPUTUM;

EID: 36249028771     PISSN: 15412555     EISSN: 15412563     Source Type: Journal    
DOI: 10.1080/15412550701597720     Document Type: Article

References (33)

1. Pin I, Gibson PG, Kolendowicz R, Girgis-Gabardo A, Denburg JA, Hargreave FE, Dolovich J. Use of induced sputum cell counts to investigate airway inflammation in asthma. Thorax 1992; 47:25-29.
2. Pizzichini E, Pizzichini MMM, Efthimiadis A, Evans S, Morris MM, Squillace D, Gleich GJ, Dolovich J, Hargreave FE. Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements. Am J Respir Crit Care Med 1996; 154:308-317.
3. Fahy JV, Wong H, Liu J, Boushey HA. Comparison of samples collected by sputum induction and by bronchoscopy from asthmatics and healthy subjects. Am J Respir Crit Care Med 1995; 152:53-58.
4. Wilson A, Leigh R, Hargreave F, Pizzichini M, Pizzichini E. Safety of sputum induction in moderate-to-severe smoking-related Chronic Obstructive Pulmonary Disease. COPD: Journal of Chronic Obstructive Pulmonary Disease 2006; 3:89-93.
5. Green RH, Brightling CE, McKenna S, Hargadon B, Parker D, Bradding P, Wardlaw AJ, Pavord ID. Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. Lancet 2002; 360:1715-1721.
6. Jayaram L, Pizzichini MM, Cook RJ, Boulet LP, Lemiere C, Pizzichini E, Cartier A, Hussack P, Goldsmith CH, Laviolette M, Parameswaran K, Hargreave FE. Determining asthma treatment by monitoring sputum cell counts: effect on exacerbations. Eur Respir J 2006; 27:483-494.
7. Bacci E, Cianchetti S, Bartoli ML, Dente FL, Di Franco A, Vagaggini B, Paggiaro P. Low sputum eosinophils predict the lack of response to beclomethasone in symptomatic asthmatic patients. Chest 2006; 129:565-572.
8. Brightling CE, Monteiro W, Ward R, Parker D, Morgan MDL, Wardlaw AJ, Pavord ID. Sputum eosinophilia and short term response to prednisolone in chronic obstructive pulmonary disease: a randomised controlled trial. Lancet 2000; 356:1480-1485.
9. Brightling CE, McKenna S, Hargadon B, Birring S, Green R, Siva R, Berry M, Parker D, Monteiro W, Pavord ID, Bradding P. Sputum eosinophilia and the short term response to inhaled mometasone in chronic obstructive pulmonary disease. Thorax 2005; 60:193-198.
10. Leigh R, Pizzichini MMM, Morris MM, Maltais F, Hargreave FE, Pizzichini E. Stable COPD: predicting benefit from high-dose inhaled corticosteroid treatment. Eur Respir J 2006; 27:964-971.
11. Paggiaro PL. Sputum induction. Eur Respir J 2002; 20:3-8.
12. Holz O, Kips JC, Magnussen H. Update on sputum methodology. Eur Respir J 2000; 16:355-359.
13. Efthimiadis A, Spanevello A. Methods of sputum processing for cell counts, immunocytochemistry and in situ hybridisation. Eur Respir J 2002; 20:19s-23s.
14. Kips JC. The use of induced sputum in clinical trials. Eur Respir J 2002; 20:47s-50s.
15. Chinn S. Repeatability and method comparison. Thorax 1991; 46:454-456.
16. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; i:307-310.
17. Holz O, Richter K, Jorres RA, Speckin P, Mucke M, Magnussen H. Changes in sputum composition between two inductions performed on consecutive days. Thorax 1998; 53:83-86.
18. Nightingale JA, Rogers DF, Barnes PJ. Effect of repeated sputum induction on cell counts in normal volunteers. Thorax 1998; 53:87-90.
19. in 't Veen JCCM, de Gouw HWFM, Smits HH, Sont JK, Hiemstra PS, Sterk PJ, Bel EH. Repeatability of cellular and soluble markers of inflammation in induced sputum from patients with asthma. Eur Respir J 1996; 9:2441-2447.
20. Brightling CE, Monterio W, Green RH, Parker D, Morgan MDL, Wardlaw AJ, Pavord ID. Induced sputum and other outcome measures in chronic obstructive pulmonary disease: safety and repeatability. Respir Med 2001; 95:999-1002.
21. Beeh KM, Beier J, Kornmann O, Mander A, Buhl R. Long-term repeatability of induced sputum cells and inflammatory markers in stable, moderately severe COPD. Chest 2003; 123:778-783.
22. Pauwels RA, Buist AS, Calverley PMA, Jenkins CR, Hurd SS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. AmJ Respir Crit Care Med 2001; 163:1256-1276.
23. Boorsma M, Lutter R, van de Pol MA, Jansen HM, Jonkers RE. Inhaled budesonide suppresses airway and systemic eosinophilic inflammation in COPD. No predictive value of a prednisolone test treatment[Abstract]. Eur Respir J 2005; 26:290s.
24. Fabbri LM, Hurd SS. Global strategy for the diagnosis, management and prevention of COPD: 2003 update. Eur Respir J 2003; 22:1-2.
25. Quanjer PhH, Tammeling GJ, Cotes JE, Pedersen OF, Yernault JC. Lung volumes and forced ventilatory flows. Report working party: Standardisation of lung function tests European Community for steel and coal. Official statement of the European Respiratory Society. Eur Respir J 1993; 6:5-40.
26. Nocker RET, Out TA,Weller FR, de Riemer MJ, Jansen HM, van der Zee JS. Induced sputum and bronchoalveolar lavage as tools for evaluating the effects of inhaled corticosteroids in patients with asthma. J Lab Clin Med 2000; 136:39-49.
27. Reimert CM, Venge P, Kharazmi A, Bendtzen K. Detection of eosinophilic cationic protein (ECP) by an enzyme-linked immunosorbent assay. J Immunol Meth 1991; 138:285-290.
28. Bresser P, Out TA, van Alphen L, Jansen HM, Lutter R. Airway inflammation in nonobstructive and obstructive chronic bronchitis with chronic Haemophilus influenzae airway infection. Am J Respir Crit Care Med 2000; 162:947-952.
29. Out TA, Jansen HM, van Steenwijk RP, de Nooijer MJ, van de Graaf EA, Zuijderhoudt FMJ. ELISA of ceruloplasmin and alpha-2-macroglobulin in paired bronchoalveolar lavage fluid and serum samples. Clin Chim Acta 1987; 165:277-288.
30. Fahy JV, Boushey HA, Lazarus SC, Mauger EA, Cherniack RM, Chinchilli VM, Craig TJ, Drazen JM, Ford JG, Fish JE, Israel E, Kraft M, Lemanske RF, Martin RJ, McLean D, Peters SP, Sorkness C, Szefler SJ. Safety and reproducibilty of sputum induction in asthmatic subjects in a multicentre study. Am J Respir Crit Care Med 2001; 163:1470-1475.
31. Swinscow TDV. Statistics at Square One (Ed 9). BMJ publishing group, 1997.
32. van der Vaart H, Postma DS, TimensW, Kauffman HF, Hylkema MN, ten Hacken NHT. Repeated sputum inductions induce a transient neutrophilic and eosinophilic response. Chest 2006; 130:1157-1164.
33. Bacci E, Cianchetti S, Carnevalli S, Bartoli ML, Dente FL, Di Franco A, Giannini D, Vagaggini B, Paggiaro PL. Induced sputum is a reproducible method to assess airway inflammation in asthma. Mediators Inflamm 2002; 11:293-298.